Trending...
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
- Lt. Governor Primavera Tours U.S. Olympic & Paralympic Museum in Colorado Springs, Highlights Investments to Increase Museum Accessibility
- $38 Million in U.S. Government Contract Awards Secured Through Strategic Partner. Establishing Multi-Year Defense Revenue Platform Through 2032: $BLIS
Through a new partnership, Acmeware will provide a FHIR-enabled integration layer that allows Avo to access MEDITECH clinical data in real time at the point of care.
MEDFIELD, Mass. - ColoradoDesk -- Acmeware, a MEDITECH Alliance Partner, announced a partnership with Avo (AvoMD), an AI platform for clinical copilots and a fellow MEDITECH Alliance Partner. Together, the organizations are enabling MEDITECH customers to seamlessly push and pull data between MEDITECH and Avo's AI-powered clinical tools. As part of this partnership, Acmeware will serve as a seamless data integration layer for Avo's AI suite within MEDITECH environments, delivering a standards-based API using the HL7® FHIR® data format.
Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.
Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.
AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.
More on Colorado Desk
"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."
The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.
"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."
The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.
Why it matters
As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.
More on Colorado Desk
For more information about Acmeware, visit www.acmeware.com.
For more information about AvoMD, visit www.avomd.com.
2 / 2
About Acmeware
Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com
About Avo
Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.
Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.
AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.
More on Colorado Desk
- Colorado: New mural enhances Firestone-Longmont Mobility Hub
- Jason Caras Launches The Caras Institute Following Successful Exit from IT Authorities
- Colorado Teen DB Henderson Wins State Poetry Out Loud Competition
- Serina Damesworth Hired as Century Fasteners Corp. – Director of Quality
- National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."
The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.
"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."
The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.
Why it matters
As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.
More on Colorado Desk
- Distributed Social Media - Own Your Content
- Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
- New Environmental Thriller "The Star Thrower" Reimagines a Classic Lesson in Individual Impact
- Summit Appoints Javier Cabeza as Data, AI, and Analytics Practice Lead
- March Is Skiing's Smartest Buying Window
For more information about Acmeware, visit www.acmeware.com.
For more information about AvoMD, visit www.avomd.com.
2 / 2
About Acmeware
Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com
About Avo
Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
Media Contact
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com
Source: Acmeware, Inc
0 Comments
Latest on Colorado Desk
- Lt. Governor Primavera Tours U.S. Olympic & Paralympic Museum in Colorado Springs, Highlights Investments to Increase Museum Accessibility
- Colorado Springs: 8th Street eastbound frontage road to reopen on Tuesday
- Celebrate Lunar New Year: The Year of the Fire Horse at the Colorado Springs Pioneers Museum
- Colorado Springs: Community Notification of a Sexually Violent Predator
- Colorado: Governor Polis Announces Lieutenant Governor Primavera as Interim Behavioral Health Commissioner
- Governor Polis Signs Bill Into Law Boosting Innovation in Agriculture and Protecting Colorado Forests from Mountain Pine Beetles
- Colorado Springs: Spring Creek Aquatic Ecosystem Restoration: Integrated Feasibility Report & Environment Assessment
- Colorado: Governor Polis Visits Community College of Aurora to Celebrate the New Center for Applied Science and Technology Building
- Purple Heart Recipient Honored by Hall of Fame Son In Viral Tribute Sparking National Conversation on Service Fatherhood, Healing and Legacy
- Colorado: CPW Offers $1 Million in Grants to Reduce Human-Bear Conflicts in Local Communities
- Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
- Primeindexer Google indexing platform launched by SEO Danmark APS
- Kaltra Introduces New Downward-Spraying Distribution Technology to Boost Microchannel Evaporator Performance
- We are all living in a simulation, and this game just proved it
- Talentica Announces Winners of Multi-Agent Hackathon 2026
- Colorado: Governor Polis Memorializes Verbal Disaster Declaration for Highly Pathogenic Avian Influenza in Weld County
- Colorado: Department of Local Affairs Announces Inaugural Transit Oriented Communities Infrastructure Grant Awards
- Special Alert: Undervalued Opportunity: IQSTEL (N A S D A Q: IQST) Positioned for Explosive Multi-Year Growth
- Triple-Digit Growth, Strategic N A S D A Q Uplist, Plus A Scalable Healthcare Rollout Model: Stock Symbol: CDIX
- Vesica Health Receives FDA Breakthrough Device Designation for AssureMDx
